wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q53573529-14E45940-63B8-45DF-AE39-317A8F13044F
Q53573529-14E45940-63B8-45DF-AE39-317A8F13044F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53573529-14E45940-63B8-45DF-AE39-317A8F13044F
Trials of new anti-diabetes agents.
P2860
Q53573529-14E45940-63B8-45DF-AE39-317A8F13044F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53573529-14E45940-63B8-45DF-AE39-317A8F13044F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6da8aeb8f1349a2b94b578eb22847edc6edd6199
P2860
Efficacy and safety of liraglutide, a once-daily human glucagon-like peptide-1 receptor agonist, in African-American people with Type 2 diabetes: a meta-analysis of sub-population data from seven phase III trials.